Cargando…
The Central Role of CD4(+) T Cells in the Antitumor Immune Response
The induction of optimal systemic antitumor immunity involves the priming of both CD4(+) and CD8(+) T cells specific for tumor-associated antigens. The role of CD4(+) T helper cells (Th) in this response has been largely attributed to providing regulatory signals required for the priming of major hi...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212434/ https://www.ncbi.nlm.nih.gov/pubmed/9858522 |
_version_ | 1782148693407825920 |
---|---|
author | Hung, Kenneth Hayashi, Robert Lafond-Walker, Anne Lowenstein, Charles Pardoll, Drew Levitsky, Hyam |
author_facet | Hung, Kenneth Hayashi, Robert Lafond-Walker, Anne Lowenstein, Charles Pardoll, Drew Levitsky, Hyam |
author_sort | Hung, Kenneth |
collection | PubMed |
description | The induction of optimal systemic antitumor immunity involves the priming of both CD4(+) and CD8(+) T cells specific for tumor-associated antigens. The role of CD4(+) T helper cells (Th) in this response has been largely attributed to providing regulatory signals required for the priming of major histocompatibility complex class I restricted CD8(+) cytolytic T lymphocytes, which are thought to serve as the dominant effector cell mediating tumor killing. However, analysis of the effector phase of tumor rejection induced by vaccination with irradiated tumor cells transduced to secrete granulocyte/macrophage colony-stimulating factor indicates a far broader role for CD4(+) T cells in orchestrating the host response to tumor. This form of immunization leads to the simultaneous induction of Th1 and Th2 responses, both of which are required for maximal systemic antitumor immunity. Cytokines produced by these CD4(+) T cells activate eosinophils as well as macrophages that produce both superoxide and nitric oxide. Both of these cell types then collaborate within the site of tumor challenge to cause its destruction. |
format | Text |
id | pubmed-2212434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1998 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-22124342008-04-16 The Central Role of CD4(+) T Cells in the Antitumor Immune Response Hung, Kenneth Hayashi, Robert Lafond-Walker, Anne Lowenstein, Charles Pardoll, Drew Levitsky, Hyam J Exp Med Articles The induction of optimal systemic antitumor immunity involves the priming of both CD4(+) and CD8(+) T cells specific for tumor-associated antigens. The role of CD4(+) T helper cells (Th) in this response has been largely attributed to providing regulatory signals required for the priming of major histocompatibility complex class I restricted CD8(+) cytolytic T lymphocytes, which are thought to serve as the dominant effector cell mediating tumor killing. However, analysis of the effector phase of tumor rejection induced by vaccination with irradiated tumor cells transduced to secrete granulocyte/macrophage colony-stimulating factor indicates a far broader role for CD4(+) T cells in orchestrating the host response to tumor. This form of immunization leads to the simultaneous induction of Th1 and Th2 responses, both of which are required for maximal systemic antitumor immunity. Cytokines produced by these CD4(+) T cells activate eosinophils as well as macrophages that produce both superoxide and nitric oxide. Both of these cell types then collaborate within the site of tumor challenge to cause its destruction. The Rockefeller University Press 1998-12-21 /pmc/articles/PMC2212434/ /pubmed/9858522 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Hung, Kenneth Hayashi, Robert Lafond-Walker, Anne Lowenstein, Charles Pardoll, Drew Levitsky, Hyam The Central Role of CD4(+) T Cells in the Antitumor Immune Response |
title | The Central Role of CD4(+) T Cells in the Antitumor Immune Response |
title_full | The Central Role of CD4(+) T Cells in the Antitumor Immune Response |
title_fullStr | The Central Role of CD4(+) T Cells in the Antitumor Immune Response |
title_full_unstemmed | The Central Role of CD4(+) T Cells in the Antitumor Immune Response |
title_short | The Central Role of CD4(+) T Cells in the Antitumor Immune Response |
title_sort | central role of cd4(+) t cells in the antitumor immune response |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212434/ https://www.ncbi.nlm.nih.gov/pubmed/9858522 |
work_keys_str_mv | AT hungkenneth thecentralroleofcd4tcellsintheantitumorimmuneresponse AT hayashirobert thecentralroleofcd4tcellsintheantitumorimmuneresponse AT lafondwalkeranne thecentralroleofcd4tcellsintheantitumorimmuneresponse AT lowensteincharles thecentralroleofcd4tcellsintheantitumorimmuneresponse AT pardolldrew thecentralroleofcd4tcellsintheantitumorimmuneresponse AT levitskyhyam thecentralroleofcd4tcellsintheantitumorimmuneresponse AT hungkenneth centralroleofcd4tcellsintheantitumorimmuneresponse AT hayashirobert centralroleofcd4tcellsintheantitumorimmuneresponse AT lafondwalkeranne centralroleofcd4tcellsintheantitumorimmuneresponse AT lowensteincharles centralroleofcd4tcellsintheantitumorimmuneresponse AT pardolldrew centralroleofcd4tcellsintheantitumorimmuneresponse AT levitskyhyam centralroleofcd4tcellsintheantitumorimmuneresponse |